Related Experiment Videos
Human T lymphocyte receptors for IgM: control by IgG-binding lymphocytes
European Journal of Immunology
|May 1, 1979
Summary
Human lymphocytes bind antibody complexes differently based on antibody type (IgG vs. IgM). Binding antigen-IgM complexes can inhibit subsequent antigen-IgG complex binding, suggesting receptor interactions on lymphocytes.
Area of Science:
- Immunology
- Cell Biology
- Lymphocyte Surface Receptors
Background:
- Human peripheral blood lymphocytes possess receptors for immunoglobulin (Ig) molecules.
- Understanding lymphocyte interactions with antibody-antigen complexes is crucial for immune response studies.
- Specific subsets of lymphocytes bind IgG and IgM antibodies via distinct surface receptors.
Purpose of the Study:
- To investigate the binding capacity of human peripheral blood lymphocytes to antigen-IgG and antigen-IgM antibody complexes.
- To explore the interaction and potential modulation between lymphocyte receptors for IgG and IgM.
Main Methods:
- Utilized a rosette technique involving ox erythrocytes (E) coated with rabbit IgG (EAG) or IgM (EAM) antibodies.
- Investigated rosette formation after pre-incubation of cell suspensions.
- Examined the effect of pre-formed rosettes or antibody complexes on subsequent rosette formation.
Main Results:
- Erythrocyte-IgM (EAM) rosette formation required a 24-hour pre-incubation period.
- Addition of either EAM or Erythrocyte-IgG (EAG) complexes inhibited EAM rosette formation.
- This inhibition was reversible and not due to IgM contamination in the IgG fraction.
Conclusions:
- Inhibition of IgM receptor expression on lymphocytes may result from modulation of IgG receptors.
- Suggests an interaction between lymphocyte subsets expressing receptors for IgG and IgM.
- Acknowledges the possibility of receptor modulation allowing cells binding EAG to subsequently express IgM receptors.